|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 1/28/20 Petmed Express Inc 10-Q 12/31/19 43:2.6M RDG Filings/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 366K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 22K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 22K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 18K
34: R1 Document And Entity Information HTML 47K
14: R2 Condensed Consolidated Balance Sheets (Current HTML 94K
Period Unaudited)
27: R3 Condensed Consolidated Balance Sheets (Current HTML 40K
Period Unaudited) (Parentheticals)
40: R4 Condensed Consolidated Statements of Comprehensive HTML 82K
Income (Unaudited)
33: R5 Condensed Consolidated Statements of Cash Flows HTML 85K
(Unaudited)
13: R6 Note 1 - Summary of Significant Accounting HTML 38K
Policies
26: R7 Note 2 - Revenue Recognition HTML 81K
39: R8 Note 3 - Net Income Per Share HTML 49K
35: R9 Note 4 - Stock-based Compensation HTML 24K
20: R10 Note 5 - Fair Value HTML 22K
17: R11 Note 6 - Commitments and Contingencies HTML 23K
29: R12 Note 7 - Changes in Shareholders' Equity and HTML 71K
Comprehensive Income
43: R13 Note 8 - Income Taxes HTML 22K
19: R14 Note 9 - Subsequent Events HTML 19K
16: R15 Significant Accounting Policies (Policies) HTML 41K
28: R16 Note 2 - Revenue Recognition (Tables) HTML 74K
42: R17 Note 3 - Net Income Per Share (Tables) HTML 45K
21: R18 Note 7 - Changes in Shareholders' Equity and HTML 67K
Comprehensive Income (Tables)
15: R19 Note 1 - Summary of Significant Accounting HTML 19K
Policies (Details Textual)
32: R20 Note 2 - Revenue Recognition (Details Textual) HTML 17K
37: R21 Note 2 - Revenue Recognition - Disaggregation of HTML 35K
Revenue by Type (Details)
25: R22 Note 3 - Net Income Per Share (Details Textual) HTML 16K
12: R23 Note 3 - Net Income Per Share - Basic and Diluted HTML 47K
Net Income Per Share (Details)
31: R24 Note 4 - Stock-based Compensation (Details HTML 39K
Textual)
36: R25 Note 5 - Fair Value (Details Textual) HTML 17K
24: R26 Note 6 - Commitments and Contingencies (Details HTML 16K
Textual)
11: R27 Note 7 - Changes in Shareholders' Equity and HTML 23K
Comprehensive Income (Details Textual)
30: R28 Note 6 - Changes in Shareholders' Equity and HTML 45K
Comprehensive Income: - Schedule of Changes in
Shareholders' Equity (Details)
38: R29 Note 8 - Income Taxes (Details Textual) HTML 26K
41: R30 Note 9 - Subsequent Events (Details Textual) HTML 27K
18: XML IDEA XML File -- Filing Summary XML 73K
23: EXCEL IDEA Workbook of Financial Reports XLSX 32K
5: EX-101.INS XBRL Instance -- pets-20191231 XML 699K
7: EX-101.CAL XBRL Calculations -- pets-20191231_cal XML 79K
8: EX-101.DEF XBRL Definitions -- pets-20191231_def XML 469K
9: EX-101.LAB XBRL Labels -- pets-20191231_lab XML 404K
10: EX-101.PRE XBRL Presentations -- pets-20191231_pre XML 490K
6: EX-101.SCH XBRL Schema -- pets-20191231 XSD 78K
22: ZIP XBRL Zipped Folder -- 0001437749-20-001273-xbrl Zip 62K
Exhibit 31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Menderes Akdag, certify that:
|
1. |
I have reviewed this report on Form 10-Q for the quarter ended December 31, 2019 of PetMed Express, Inc.; |
|
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
|
4. |
The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5. |
The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of the internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s Board of Directors (or persons performing the equivalent functions): |
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
|
|
||
|
|
|
|
|
|
|
By: |
/s/ Menderes Akdag |
|
|
|
|
||
| Chief Executive Officer and President | |||
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 1/28/20 | None on these Dates | ||
| For Period end: | 12/31/19 | |||
| List all Filings | ||||